🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
This phase III trial studies rituximab after stem cell transplant and to se...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-11-27
Trial ID
NCT03267433
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Active Not Recruiting
Location
Alaska Breast Care and Surgery LLC
Start Date
2012-08-09
Trial ID
NCT01415752
Treatments Being Tested
This phase II trial tests how well epcoritamab in combination with rituxima...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-07-27
Trial ID
NCT07365306
Phase II trial to study the effectiveness of combining rituximab and rasbur...
Status
Completed
Location
Children's Oncology Group
Start Date
2004-06
Trial ID
NCT00057811
The purpose of this study is to show if addition of Rituximab to intensive ...
Status
Completed
Location
University Hospital Brno-Bohunice
Start Date
2002-05
Trial ID
NCT00558220
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Leeds Cancer Centre at St. James's University Hospital
Start Date
2007-06
Trial ID
NCT00689845
The investigators would like to propose a phase-2 prospective multicenter t...
Status
Unknown
Location
Chonnam National University Hwasun Hospital
Start Date
2011-11
Trial ID
NCT01429610
Treatments Being Tested
This phase II trial is studying how well giving rituximab together with com...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
2007-05
Trial ID
NCT00433537
A Phase II, open-label, two-arm, multicenter study evaluating the combinati...
Status
Not Yet Recruiting
Location
Zuckerberg San Francisco General
Start Date
2026-09-15
Trial ID
NCT07588698